Real-World Outcomes and Cardiac Implications of FLT3 Inhibitors in Acute Myeloid Leukemia

lestaurtinib (CEP-701) - Teva, Kyowa Kirin

Xospata (gilteritinib) - Astellas

Vanflyta (quizartinib) - Daiichi Sankyo

sorafenib - Generic mfg.

Rydapt (midostaurin) - Novartis

crenolanib (ARO-002) - AROG

https://ash.confex.com/ash/2022/webprogram/Paper169932.html

Vikram Dhillon, DO1*, Abdul Moiz Khan, MD2, Ali Al Sbihi, MD1*, Sushmitha Nanja Reddy, MBBS1*, Enxhi Lalo3*, Harry Ramos3*, Jay Yang, MD4, Anupama Kottam, MD5* and Suresh Kumar Balasubramanian, MD4

Nov 4, 2022